PROGRAMME

Introduction lectures

• Viruses associated to cancer and their distribution in the world; focus on HPV
  

  Dr. M. Tommasino (International Agency for Research on Cancer - World Health Organization)

• The INCA project "The role of chronic infections in the development of cancer" funded by the EC; Short overview on "virus and cancer"
  

  Pr. T.F. Schulz (Institut für Virologie, Medizinische Hochschule Hannover)

Infection & Cancer Research & Development in the region
Chairman: Pr. Christian TREPO

Poster presentations (click on titles to see abstracts)

• HBZ (HTLV-1 bZIP factor) cooperates with JunD to activate transcription of the human telomerase reverse transcriptase gene (hTERT)
• HTLV-1 Tax protein downregulates pre-Ta gene expression human immature thymocytes
• Dissecting and targeting telomerase, telomeres and telosomic dysregulation during virus-associated carcinogenesis
• Epstein-Barr Virus (EBV) in breast cancer: A positive image at last?
• Cycle productif du virus d’Epstein-Barr: Contrôle de l’activation du cycle par la protéine transactivatrice virale EB1 et export des ARNm viraux par le facteur viral EB2
• Presence of invasive Escherichia coli in colorectal cancer biopsies
• Synthesis and Atomic Force Imaging of Amphiphilic Peptidyl-RNA Conjugates
• Lymphocytes T cytotoxiques chimériques anti-CD33 pour le traitement des leucémies myéloïdes CD33+ : preuve de concept et perspectives cliniques
• Immune system of the liver is altered during Chronic Hepatitis C infections and in Hepatocellular Carcinoma
• TRANSAT : Créateur en ingénierie cellulaire
• A novel vaccine candidate against hepatitis C virus (HCV) combining a vector derived from live measles vaccine and HCV viral-like particles
• La méthode IDADIGE (Image and Data Analysis for Differential In Gel Electrophoresis)
• Clonopathies oligoclonales de signification indéterminée
• Outils de validation cytomique d'expression protéomique des adénocarcinomes
• HPV high-risk types suppress the transcriptional activity of TLR9 in human primary epithelial cells: a new mechanism for viruses to escape innate immune recognition?
• Skin human papillomavirus type 38 alters p53 functions by accumulation of ?Np73

On-going projects in the region

• BIOTHERAPIC, biotherapies of chronic infectious diseases, therapeutic vaccination against HCV infections:
  

  Dr. G.Inchauspé, Transgene

• DEMINAP, Utilisation des récepteurs Toll-like (TLR) pour la détection de microorganismes inapparents et de leurs ligands à des fins diagnostiques et thérapeutiques (Innate Pharma, bioMerieux, Inserm 590 Léon Bérard Cancer Centre, International Agency for Research on Cancer - World Health Organization)
  

  Dr. C. Caux (CLB) and Dr. D. Lamy (bioMérieux)

• LYMPHOS1, Monitoring TCR repertoire distortions to predict lymphopenia and prevent death through fatal infection as a risk of chemotherapy (ImmunID, Inserm 590 Léon Bérard Cancer Centre)
  

  Dr. N. Pasqual, ImmuID

• PRAVIC, Recombinant proteins with immunomodulatory and anti tumoral properties (OPi, Lyon University Hospital, Léon Bérard Cancer Centre)
  

  Dr. C. Vermot-Desroche, OPi

• MVA-HPV-IL2 (Transgene)
  

  Dr. G.Inchauspé, Transgene

Scientific Committee meeting
Chairman: Pr. Eric Wattel

Click on the following links to see presentations:

	Compte-rendu du Comité Scientifique (95,67 kB)

	Viruses associated to cancer (535,88 kB)

	The INCA project (144,19 kB)

	Poster presentations (1,43 MB)

	BIOTHERAPIC (179,21 kB)

	DEMINAP (638,61 kB)

	LYMPHOS1 (462,95 kB)

	PRAVIC (281,02 kB)

	MVA-HPV-IL2 (157,15 kB)